Zacks Research Analysts Lower Earnings Estimates for Danaher

Danaher Co. (NYSE:DHR) – Research analysts at Zacks Research reduced their Q2 2025 EPS estimates for Danaher in a research note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now expects that the conglomerate will post earnings of $1.77 per share for the quarter, down from their prior estimate of $1.85. The consensus estimate for Danaher’s current full-year earnings is $7.67 per share. Zacks Research also issued estimates for Danaher’s Q3 2025 earnings at $1.86 EPS, FY2025 earnings at $7.62 EPS, Q1 2026 earnings at $1.86 EPS, Q2 2026 earnings at $2.05 EPS, Q3 2026 earnings at $2.06 EPS, Q4 2026 earnings at $2.54 EPS, FY2026 earnings at $8.51 EPS and FY2027 earnings at $9.43 EPS.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business posted $2.09 earnings per share.

Several other brokerages also recently commented on DHR. Barclays dropped their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Robert W. Baird dropped their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Guggenheim assumed coverage on shares of Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

NYSE DHR opened at $208.10 on Friday. The stock has a 50-day simple moving average of $227.21 and a 200 day simple moving average of $247.52. Danaher has a twelve month low of $196.80 and a twelve month high of $281.70. The stock has a market capitalization of $150.31 billion, a PE ratio of 39.41, a P/E/G ratio of 2.61 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Hedge Funds Weigh In On Danaher

Several institutional investors have recently bought and sold shares of DHR. Norges Bank acquired a new position in Danaher during the 4th quarter worth about $2,130,740,000. FMR LLC raised its stake in shares of Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Danaher during the fourth quarter worth approximately $391,172,000. Two Sigma Advisers LP grew its stake in shares of Danaher by 4,248.8% during the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock valued at $376,347,000 after purchasing an additional 1,601,800 shares during the last quarter. Finally, Capital World Investors increased its holdings in shares of Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.62%. Danaher’s payout ratio is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.